Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV–HIV-coinfected patients
Version of Record online: 15 MAR 2012
© 2012 Blackwell Publishing Ltd
Journal of Viral Hepatitis
Volume 19, Issue 11, pages 801–810, November 2012
How to Cite
Kosi, L., Reiberger, T., Payer, B. A., Grabmeier-Pfistershammer, K., Strassl, R., Rieger, A. and Peck-Radosavljevic, M. (2012), Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV–HIV-coinfected patients. Journal of Viral Hepatitis, 19: 801–810. doi: 10.1111/j.1365-2893.2012.01601.x
- Issue online: 9 OCT 2012
- Version of Record online: 15 MAR 2012
- Received November 2011; accepted for publication January 2012
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.